WINDLAS — Windlas Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual balance sheet for Windlas Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,787	1,320	2,045	2,395	2,798
Net Total Accounts Receivable
Net Total Receivables	1,171	1,174	1,377	2,011	2,274
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	3,817	3,535	4,313	5,251	6,269
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	983	1,227	1,803	2,219	2,660
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	4,910	5,290	6,262	7,605	9,073
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	940	1,212	1,718	2,494	2,911
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	962	1,267	1,763	2,547	3,265
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	3,948	4,023	4,499	5,058	5,808
Total Liabilities & Shareholders' Equity	4,910	5,290	6,262	7,605	9,073
Total Common Shares Outstanding